Regional cancer in this staging system is equivalent to stage 3 in the AJCC system. According to data from the NCI’s SEER program , 33% of anal cancers diagnosed in the United States between ...

The latest version introduces Microsoft Word integration, DICOM Modality Worklist, and HL7 inbound scheduling support.

To provide quality care to patients, clinicians need to understand high-risk melanoma diagnosis, treatment, and side effect management. News & Perspective Drugs & Diseases ...

Staging for small cell lung cancer (SCLC) can help identify how advanced the cancer is and its best treatment. Read about its diagnosis and the TNM staging system.

AJCC Cancer Staging Manual (8th edition) American Joint Committee on Cancer Springer, 2017. Lung cancer: diagnosis and management. National Institute for Health and Care Excellence, March 2019 ...

Stage 1: A surgeon will typically remove the gallbladder.This should be the only treatment a person needs at this stage. However, if the cancer has grown through the muscular layer of the ...

Late stage (stage 3) testicular cancer has spread to distant body parts or the area around your testicle. Learn about the symptoms, treatment, and outlook.

In multivariable analysis that included key AJCC staging criteria (i.e., Breslow thickness, ulceration and nodal status) and other commonly used clinicopathologic risk factors (e.g., age and ...

Stage 1 lung cancer. The stage of a cancer tells you how big it is and whether it has spread. It helps your doctor decide which treatment you need. It can also give some idea of your outlook ...

FRIENDSWOOD, Texas - A recent study published in the journal Cancers has provided evidence that Castle Biosciences Inc .'s (NASDAQ:CSTL) DecisionDx-Melanoma test offers better risk stratification ...

This was a multi-institutional phase II trial of neoadjuvant osimertinib for patients with surgically resectable stage I-IIIA (American Joint Committee on Cancer [AJCC] V7) EGFR-mutated (L858R or exon ...

FRIENDSWOOD, Texas - A recent study published in the journal Cancers has provided evidence that Castle Biosciences Inc .'s (NASDAQ:CSTL) DecisionDx-Melanoma test offers better risk stratification for ...